Home › NDC Lookup › Ingredients › Rifampin › 60687-0575-21
💊image loading
(from DailyMed)

Rifampin 150 mg Capsule, 30-count — NDC 60687-575-21 (Billing 60687-0575-21)

by American Health Packaging · 30 BLISTER PACK in 1 BOX, UNIT-DOSE / 1 CAPSULE in 1 BLISTER PACK

This is a package of 30 capsules of Rifampin 150 mg Capsule from American Health Packaging, marketed since Mar 2021 and currently FDA-listed; retail pharmacies pay about $0.8978 per capsule (NADAC). It is this product's only package size.

NDC 60687-0575-21
🏷️ FDA NDC (as labeled) 60687-575-21 billing pads the product segment with a zero
Rx only Generic On market Non-controlled ⇄ Compare with another NDC
🗂️ FDA directory synced Oct 8, 2026 · this listing last changed Oct 8, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →

This page is curated, coded, and maintained by

Compiled from public FDA, CMS, DailyMed, NADAC, and related drug data sources. Editorial policy

NDC database record

One package, one record: these facts belong to NDC 60687-575-21 alone.

Record
FDA NDC Directory package listing · Human prescription drug
Code segments
60687 labeler · 575 product · 21 package
Package marketed since
Mar 5, 2021
Sample package
No — commercial package
Listing certified through
Dec 31, 2027
Billing quantity
30 EA per package
Barcode (UPC-A, from the NDC)
3 6068757521 6
FDA record last changed
Oct 8, 2026
Past resolved recalls for this product (2)
Class II · Jan 11, 2024 · Terminated — Failed Impurities/Degradation Specification. (Amerisource Health Services LLC) · FDA recall D-0285-2024
Class II · Dec 20, 2022 · Terminated — Failed Impurities/Degradations Specifications (Amerisource Health Services LLC) · FDA recall D-0165-2023

Identity & classification

Regulatory identifiers FDA, NLM and CMS codes for this package

FDA NDC (as labeled) 60687-575-21
Product NDC 60687-575
11-digit billing NDC 60687057521
NCPDP billing unit EA — each (per item)
Application # ANDA090034
SPL Set ID 5c294d0f-3e73-f2ff-e063-6294a90adadc
Established class (EPC) Rifamycin Antibacterial
Chemical class Rifamycins
DEA schedule Non-controlled
Marketing category ANDA
Marketing status On market
FDA listing status Listed (active directory)
Marketing start 2021-03-05
Route ORAL
Dosage form CAPSULE
Substance RIFAMPIN
TE code (Orange Book) AB · RLD · RS

Drug-database identifiers Medi-Span GPI and First Databank GCN / HICL / AHFS classification

GCN Seq No 009322
GCN 41260
HICL code 004040
Ingredient (HICL) Rifampin
HIC1 code W
Therapeutic class — broad (HIC1) Anti-Infecting Agents
HIC2 code W1
Therapeutic class — intermediate (HIC2) Antibiotics
HIC3 code W1G
Therapeutic class — specific (HIC3) Antitubercular Antibiotics
AHFS code 08:12.28.30
AHFS class Rifamycin Antibiotics
FDB label name RIFAMPIN 150 MG CAPSULE
FDB brand name Rifampin
Legend status F — Federal legend — prescription drug or device
Quick answers
  • GSN (GCN sequence number): 009322
  • GCN: 41260
  • HICL (First Databank): 004040
  • AHFS class code: 08:12.28.30
Why two NDCs? The FDA registers this code as 60687-575-21 — a 5-3-2 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the product segment → 60687-0575-21. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.

Clinical

Label name RIFAMPIN 150 MG CAPSULE Ingredient Rifampin
📖 What it is MedlinePlus · NLM

Rifampin is used with other medications to treat tuberculosis (TB; a serious infection that affects the lungs and sometimes other parts of the body). Rifampin is also used to treat some people who have Neisseria meningitidis (a type of bacteria that can cause a serious infection called meningitis) infections in their noses or throats. These people have not developed symptoms of the disease, and this treatment is used to prevent them from infecting other people. Rifampin should not be used to treat people who have developed symptoms of meningitis. Rifampin is in a class of medications called an...

Read the full MedlinePlus article ↗
📗 Our plain-language guide HelloPharmacist
  • It treats all forms of tuberculosis, always alongside other TB medicines. It is also used to clear meningococcal bacteria from the nose and throat of people who carry them without...
  • Take them once daily, either 1 hour before or 2 hours after a meal, with a full glass of water. Food can lower how much gets absorbed. Take every dose as prescribed, even when you...
  • That is expected. Rifampin can turn urine, sweat, saliva and tears orange-red. It is harmless but can stain things. It can also permanently discolor teeth.
  • Rifampin can lower the effect of hormonal birth control such as pills. The label advises switching to a non-hormonal method while you are on it. Talk with your prescriber about opt...
📖 Read our full Rifampin guide →
8
Nutrient depletion considerations

Rifampin may be associated with lower levels of 8 nutrients — worth a chat with your pharmacist, not a cause for alarm.

🧪 Full Rifampin nutrient depletion report →
An association is not a deficiency. Educational only — don't start or stop anything without professional guidance.
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.

Pricing

A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.

Price systemPer eaPer package
Retail pharmacies payNADAC · weekly $0.898 $26.93 / 30 capsule
Medicaid paysCMS SDUD · 12 mo No recent Medicaid claims on file for this NDC — rare and low-volume NDCs are suppressed in the public data.
Medicare drug plans payPart D · Q2 2026 $1.19 $35.83 / 30 capsule
NADAC price history (per ea) — tap or hover for the price & month
Nov 2021 Jul 2022 Feb 2026 Sep 2026 $1.317 $0.596
▼ Down 11% over the last 20 months.
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.

Packaging — all sizes for this product

Package NDCDescription Marketing startMarketing endStatus
60687-0575-21 You're viewing this Main listing 30 BLISTER PACK in 1 BOX, UNIT-DOSE / 1 CAPSULE in 1 BLISTER PACK 2021-03-05 — Active

Therapeutic equivalents

ProductLabelerPackNADAC/unitTEStatusPrice vs. this
rifampin 150 mg 68180-0658-01 Lupin 60 capsules $0.825 AB Discontinued save 8%
Rifampin 150 mg 24658-0801-30 PURACAP 30 capsules $0.898 AB Availability likely —
Rifampin 150 mgthis 60687-0575-21 American 30 capsules $0.898 AB Availability likely —
Rifampin 150 mg 70954-0892-10 ANI 30 capsules $0.898 AB Availability likely —
Rifampin 150 mg 42806-0801-01 EPIC 100 capsules — AB FDA listed —
Rifampin 150 mg 62135-0315-30 Chartwell 30 capsules — AB FDA listed —
Rifampin 150 mg 67046-1605-03 Coupler 30 capsules — AB FDA listed —
About this product: this is a generic version of the medicine. FDA equivalence ratings are shown when available, and other versions are listed above, least expensive first.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.

Availability & generic status

🏛️
2021
On the market since
Mar 2021
📍
2026
Currently FDA-listed
5 years listed
🔓
·
Generic on the market
this product is a generic
✅This is a generic drug

This product is an FDA-approved generic. Other versions of the same drug are listed under Therapeutic equivalents, least expensive first.

Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.

Inactive Ingredients / Excipients

Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.

🧪 Avoiding an ingredient? See Rifampin inactive ingredients by manufacturer: every current product's list side by side, so you can ask your pharmacy for the version that does not list it.

Loading inactive ingredients from the official FDA label in the background. No external source is being called by this page request.
Where does this data come from?
Source: official FDA Structured Product Labeling (SPL) via DailyMed and the openFDA label index. Structured IACT rows and label-wide narrative are kept separate; availability and product-level specificity depend on the submitted label.

Inactive ingredient FAQ

Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.

Manufacturer & labeler

LabelerAmerican Health Packaging
Application holderLUPIN PHARMACEUTICALS INC
FDA applicationANDA090034 (ANDA)
Labeler code60687
First marketedMar 2021
Product typeHuman Prescription Drug
Portfolio674 products on file

More NDCs from American Health Packaging labeler code 60687

The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.

Full prescribing information FDA SPL

The complete FDA label for this product — the official prescribing information, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
📄 FDA label
📄 FDA label 19 words ▾

No FDA label is on file for this product yet. Labels load from openFDA / DailyMed and refresh weekly.

Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA. Prefer the government’s original formatting? View this label on DailyMed ↗

Medicare Part D spend CMS · PART D · 2026 (Q1)

Medicare Part D (outpatient prescription) spending for Rifampin — the program that covers self-administered drugs. 6 manufacturers.
⚠️ Drug-level data: CMS publishes Part D spending by drug, not by NDC — these figures combine every manufacturer, strength and package size sold under the name Rifampin. That’s a different level of aggregation than the Medicaid card above, which is specific to this exact 11-digit NDC (pack size included), so the two aren’t directly comparable.
Period
Total Part D spend
$2.06M
Claims incl. refills
26.8K
Beneficiaries
16.2K
Spend / beneficiary
$127.01
Spend / claim
$76.95
Trend by period
💵 About the dollar figures: spending is what Part D plans paid before confidential manufacturer rebates, so the program’s real net cost is lower. A blank patient count means fewer than 11 people — CMS hides counts that small to protect privacy. Source: CMS Medicare Quarterly Part D Spending by Drug (data.cms.gov), updated quarterly.
← 60687-0572-32 · American 60687-0576-10 · American →
For educational and professional reference only — not medical advice. Pricing reflects published NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.